0 التعليقات
0 المشاركات
511 مشاهدة
0 معاينة
البحث
إكتشاف أشخاص جدد وإنشاء اتصالات جديدة وصداقات جديدة
-
الرجاء تسجيل الدخول , للأعجاب والمشاركة والتعليق على هذا!
-
Global Fill Finish Manufacturing Market Forecast to Reach USD 37.8 Billion by 2036, USA Registers 9.8% CAGRThe fill finish manufacturing market is forecast to expand from USD 15.9 billion in 2026 to USD 37.8 billion by 2036, registering a 9.1% CAGR over the forecast period. Fact.MR attributes this expansion to increasing demand for injectable pharmaceuticals, growing biologics and vaccine production, and greater outsourcing of sterile manufacturing operations. The market is also being shaped by...0 التعليقات 0 المشاركات 26 مشاهدة 0 معاينة
-
North America Fill Finish Manufacturing Market Growth: Aseptic Filling AdvancesThe North America fill finish manufacturing market is supported by a strong biopharmaceutical manufacturing base, advanced aseptic technologies, and increasing demand for injectable therapies. Growing outsourcing of filling and packaging activities to CMOs and CDMOs, along with the adoption of prefilled syringes, vials, and cartridges, is creating further opportunities across the region. The US...0 التعليقات 0 المشاركات 213 مشاهدة 0 معاينة
-
What Comes Next for the Fill-finish Pharmaceutical Contract Manufacturing Market Through 2030The global fill-finish pharmaceutical contract manufacturing market was valued at USD 18.0 billion in 2024 and is expected to reach USD 29.1 billion by 2030, expanding at a CAGR of 8.3% from 2025 to 2030. The market is projected to grow from USD 21.1 billion in 2026 to USD 29.1 billion by 2030. North America held the leading position in 2024, accounting for 34.9% of global revenue. The growing...0 التعليقات 0 المشاركات 271 مشاهدة 0 معاينة
-
United States Sterile Fill-Finish for Cell and Gene Therapies Market Growing at 8.9%According to a new report from Intel Market Research, the United States Sterile Fill-Finish for Cell and Gene Therapies Market was valued at USD 0.54 billion in 2025 and is projected to reach USD 1.04 billion by 2034, growing at a robust CAGR of 8.9% during the forecast period (2025–2034). This expansion is driven by accelerating investments in cell‑and‑gene therapy pipelines, supportive...0 التعليقات 0 المشاركات 2كيلو بايت مشاهدة 0 معاينة